Skip to main content

Ovarian Cancer

EFFORT Study of Adavosertib with or without Olaparib in Women with PARP-Resistant Ovarian Cancer

Final Overall Survival Results from the LIGHT Study of Olaparib Treatment in Platinum-Sensitive Relapsed Ovarian Cancer by BRCA Mutation and Homologous Recombination Deficiency Status

Phase 3b OPINION Primary Analysis of Olaparib Maintenance Monotherapy for Nongermline BRCA1/2-Mutated Platinum-Sensitive Relapsed Ovarian Cancer

Ovarian Cancer Year In Review Introduction

First-Line Maintenance Setting in Patients with Recurrent Ovarian Cancer: Individualized Starting Dose of Niraparib Recommended

Efficacy and Safety of Niraparib in Older Patients with Advanced Ovarian Cancer

A Systematic Review of Robotic Interval Debulking Surgery for Advanced Epithelial Ovarian Cancer

Phase 2 OVARIO Study: Promising Survival Rates with Niraparib plus Bevacizumab in Women with Advanced Ovarian Cancer

Starting Dose of Rucaparib in Patients with Recurrent Ovarian Cancer Based on a Pooled Analysis

The Efficacy of Niraparib in Patients with Advanced Ovarian Cancer Extends to All Biomarker Subgroups

1
2
3
4
5
6
7

Page 4 of 13
Results 31 - 40 of 125